SCHEMBL22260282

SCHEMBL22260282

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc5c(ccc6c7ccc8c9ccccc9c9ccccc9c8c7oc56)c4)cc3)c3ccccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.44
ESR2 Q92731 3/20 0.44
GPR84 Q9NQS5 1/20 0.41
CYP1A2 P05177 8/20 0.40
CYP1A1 P04798 8/20 0.40
CYP1B1 Q16678 8/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2B6 P20813 2/20 0.40
CYP2C19 P33261 2/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
PRKDC P78527 2/20 0.40
KDM4E B2RXH2 1/20 0.40
PDE5A O76074 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
ABCB1 P08183 1/20 0.40
MAPT P10636 1/20 0.40
CYP19A1 P11511 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079927 0.99 ESR1 (0.43) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19080050 0.94 CYP1A1 (0.40) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL22260544 0.92 CYP1A1 (0.45) CYP1A2CYP1A1CYP1B1CYP3A4CYP2D6
SCHEMBL19079996 0.91 CYP1A1 (0.45) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19079933 0.91 CYP1A1 (0.44) CYP1A2CYP1A1CYP1B1CYP3A4CYP2D6
SCHEMBL19079923 0.90 CYP1A1 (0.50) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19080042 0.88 CYP1A1 (0.43) CYP1A2CYP1A1CYP1B1CYP3A4CYP2D6
SCHEMBL19080029 0.88 ARSA (0.38) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19080107 0.87 CYP1A1 (0.47) ESR1ESR2GPR84CYP1A2CYP1A1
SCHEMBL19079959 0.86 ARSA (0.39) CYP1A2CYP1A1CYP1B1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200235315-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TRPA1, PIEZO1, SLCO4C1 ESR1 363/4885ESR2 1208/4885GPR84 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.